AllDocs -> cancers

Cancer The building blocks of the body are cells, which normally repair and reproduce in a controlled process. With cancer, this process goes wrong and cells divide and grow in an uncontrolled way. The body is made up of many different types of cells, such as skin, nerve, muscle and blood cells. With leukaemia , it is white blood cells that are affected. About leukaemia White blood cells are produced by the bone marrow, the soft spongy centre of bones. They then pass from the bone marrow into the blood stream and lymph system. White blood cells are involved in various functions of the immune system (the body’s defence system), which protects the body from infections. In leukaemia , some blood cells do not grow properly, but remain within the bone marrow and continue to reproduce in an uncontrolled way. These cells fill up the bone marrow ...

www.verdinrete.it/ondakiller A POOLED ANALYSIS OF MAGNETIC FIELDS AND CHILDHOOD LEUKAEMIA by Anders Ahlbom1, Nick Day2, Maria Feychting1, Eve Roman3 , Jane Skinner2, John Dockerty4, Manna Linet5, Mary McBride6 , Jorg Michaelis7 Jorgen H. Olsen8 , Tore Tynes9 & Pia K Verkasalo10.11.12 1Division of Epidermiology, National Institute of Environmental Medicine, Karolinska Institute, Sweden 2Strangeways Research Laboratory, University of Cambridge, United Kingdom 3Leukaemia Research Fund Centre for Clinical Epidemiology, University of Leeds, United Kingdom 4Childhood Cancer Research Group, University of Oxford, United Kingdom 5 Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA 6Cancer Control Research Programme, British Columbia Cancer Agency, Canada 7Institute of Medical Statistics and Documentation, University of Mainz, Germany 8Institute of ...

ADULT LEUKAEMIA WORKING PARTY SERIOUS ADVERSE EVENT REPORT Patient Identification: Name: . Trial No: . Centre: . Consultant: . Associated Drug: Trial: PT1: Anagrelide AML: ATRA Fludarabine PSC-833 HD AraC (A400) Other: . Adverse Event: Definition:- A severe adverse event is any unexpected event, which may be related to the drug, which is (a) life threatening, or (b) requires admission to hospital, or (c) results in significant disability, or (d) results in cancer. SAE: . Details:

The Ulster Medical Journal, Volume 71, No. 1, pp. 72-75, May 2002. Case Report Acute B Cell Lymphoblastic Leukaemia and Human Immunodeficiency Virus Infection (HIV) J Hamilton, M McBride, P Kettle Accepted 24 April 2002 Highly active anti-retroviral therapy (HAART) and prophylactic therapy for opportunistic infection have significantly improved the survival and quality of life for patients infected with the Human Immunodeficiency Virus (HIV). 12 Lymphoproliferative disease complicates the clinical course of HIV infection in approximately 10% of patients and the incidence of Non Hodgkins Lymphoma is 60-200 times more common than the general population. 34 Diffuse large B cell lymphoma, Burkitt's Lymphoma, Burkitt like Lymphoma and Primary Cerebral Lymphoma are the most common subtypes with Hodgkins Disease, Plasmacytoma and ...

Aetiology of Childhood Leukaemia Tracy Lightfoot Epidemiology & Genetics Unit Page 2 Childhood Cancer 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% leukaemia brain lymphoma soft tissue sarcoma neuroblastoma kidney bone germ cell retinoblastoma epithelial liver other Page 3 What is Leukaemia ? • Leukaemia is a clonal disease originating in a single cell • It evolves by the accrual of mutations within a clone resulting in genetic diversification • Dominant mutant subclones are then naturally selected • The nature of the clone and how far it has evolved determines the clinical outcome • Delay in diagnosing increases the likelihood that the clone will have ...

leukaemia THE EXPOSURE OF T-LYMPHOBLASTOID LEUKAEMIA CCRF-CEM CELLS TO 900 MHZ ELECTROMAGNETIC FIELD MODULATES GENE EXPRESSION AFFECTING CELL PROLIFERATION, APOPTOSIS AND CELL-CYCLE CONTROL. MARINELLI F., LA SALA D., CATTINI L. §, TOMASSETTI G.*, CICCIOTTI G. AND CINTI C. Inst. of Cytomorphology N. P. CNR- c/o I.O.R. Via di Barbiano 1/10 40136 Bologna Italy. § Inst. of Immunology and genetics IOR-Bologna Italy. Inst. of Radioastronomy CNR-Bologna Italy. Abstract It is becoming increasingly evident that electromagnetic radiation (NIR) is able to produce effects on biological systems and cells at biochemical and molecular level with effects independent from thermal phenomena (Barnes 1996, Astumian et al.1995, Litovitz et al. 1993). Recent studies have shown that NIR can affects cell metabolism and proliferation, inducing potentially damaging effects in all cellular compartments, ...

The Leukaemia Foundation's World's Greatest Shave for a Cure Can you cut it? The World's Greatest Shave for a Cure is a fundraising event for the Leukaemia Foundation where participants shave or colour their hair to raise funds for leukaemia research and patient support. To encourage you in your sacrifice, people sponsor you, and in return for their donation, the sponsor has the pleasure of seeing you go hairless or coloured. In 2003, over 50,000 participants in World's Greatest Shave for a Cure raised more than $9.3 million. In 2004, we're aiming for over $10 million, and 60,000 shaved or coloured heads! Anyone can participate in the World's Greatest Shave for a Cure (WGS), including individuals, teams, schools, community groups, clubs and businesses. The Leukaemia Foundation encourages participants to challenge workmates, friends and associates to equal their efforts by also ...

leukaemia River Tay - Leukaemia Marathon Sunday 16th May 2004 Start: Forestry Commission Car Park at Dalerb on the north side of Loch Tay. From Aberfeldy take the A827 to Kenmore, turn right across the end of the Loch, pass through the village and continue on the north side of the Loch to the Forestry Commission Car Park. Briefing for both Long and Short course at 12.00 noon. Long Course: From Forestry Commission Car Park to Grandtully rapids Distance: 13 miles Start: 12.30 p.m. Short Course: From Forestry Commission Car Park to Aberfeldy Distance: 7 miles Start: 12.30 p.m. There is no Mini Course There are stretches of white water over the first 2 miles of the river and the final 3 miles of the long course. Overstern ...

1. Introduction It is generally accepted that allogeneic stem cell transplantation (allo-SCT) has the potential to cure sel- ected patients with chronic myeloid leukaemia (CML) and that cure depends on the contribution of a poorly defined ‘graft-versus- leukaemia ’ effect [1]. However, there is a significant risk of morbidity or mortality as a direct consequence of the procedure. The introduction of interferon-alpha (IFN-ï ) in the 1980s complicated the decision whether or not to recommend allo-SCT and the early clinical experience with the Abl signal transduction inhibitor imatinib has made the decision making process yet more complex. Here we define the current problem in general terms and suggest some tentative recom- mendations. We recognize that these recommendations may be valid for only a limited period. 2. Predicting Survival with Non-Transplant Therapy ...

Abstract. Vincristine (VCR), a microtubule interfering anti- cancer agent, plays a key role in the treatment of childhood acute lymphoblastic leukaemia (ALL). The route of VCR induced apoptosis in ALL cells is not well defined. In this study we demonstrated caspase-9 and -3 activation in vivo in bone marrow leukaemic cells of a child with newly diagnosed ALL, after treatment with a single dose of VCR. We hypothe- sized that VCR induced apoptosis in ALL cells proceeds by a mitochondrial controlled pathway. We further studied the route of VCR induced apoptosis in Jurkat acute lymphoblastic leukaemia cells. First we showed that VCR induces activation of caspase-9 and -3 in Jurkat cells. With the caspase-9 inhibitor Z-LEHD-FMK we proved that caspase-9 was activated prior to caspase-3. Loss of mitochondrial transmembrane potential was independent of caspase-9 activation. To confirm the ...

LEUKAEMIA R E S E A R C H Hodgkin’s disease & other lymphomas myeloma • myelodysplasia • aplastic anaemia the myeloproliferative disorders • the leukaemias Page 2 Acknowledgements Leukaemia Research Fund gratefully acknowledges the help and advice of Professor A. V. Hoffbrand in reviewing this series of publications and the assistance of Professor A. Burnett, Professor D. Catovsky, Professor J. Chessells, Professor J. Goldman, Dr A. Haynes, Professor G. Morgan, Dr S. O’Brien, and Professor J. Sweetenham in the preparation of specific titles. Published by Leukaemia Research Fund , April 2001 43 Great Ormond Street London WC1N 3JJ Tel: 020 7405 0101 Email: info@lrf.org.uk Fax: 020 7242 1488 Web: www.lrf.org.uk Registered Charity 216032 © All rights reserved. No part of this publication may be reproduced ...

Association of early life factors and acute lymphoblastic leukaemia in childhood: historical cohort study L Murray* ,1 , P McCarron 1,2 , K Bailie 3 , R Middleton 1 , G Davey Smith 4 , S Dempsey 5 , A McCarthy 5 and A Gavin 1 1 Northern Ireland Cancer Registry, Department of Epidemiology and Public Health, The Queens University, Belfast, Riddel Hall, Stranmillis Road, Belfast BT9 5EE, UK; 2 Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, USA; 3 Ulster Community & Hospitals Trust, Belfast, UK; 4 Department of Social Medicine, University of Bristol, Bristol, UK; 5 Royal Group of Hospitals Trust, Belfast, UK In a historical cohort study of all singleton live births ...